BIIB143, also known as cemdomespib, was the most advanced asset to get the chop. Biogen acquired the Hsp90 modulator in 2023 through its buyout of Reata, a deal that centered on the FDA-approved ...

Morgan Stanley analyst Terence Flynn has maintained their neutral stance on MRK stock, giving a Hold rating yesterday.Invest with Confidence: ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.BoQAct6R.js ...

While there are risks, such as challenges with chip cadence and high CapEx requirements ... to Nvidia from deals with biotech and pharmaceutical companies. For example, the deal with IQVIA ...

As clinical trial complexity, duration, and cost continue to rise, life sciences companies are turning to data to help them ...

LONG BEACH, Calif. - Rocket Lab USA, Inc. (NASDAQ:RKLB), a provider of launch services and space systems valued at $14.1 billion, has announced the delivery of its third Pioneer spacecraft to Varda ...

Chief R&D and commercial officer Najat Khan, PhD, tells GEN Edge the company aims to improve design of studies, accelerate enrollment, and enhance evidence generation.

Its cadence of annual VOXZOGO revenues in millions ... Changes in treatment method can be caused by the introduction of other companies’ products or the development of new technologies or ...

Q4 2024 Earnings Call Transcript February 6, 2025 Neurocrine Biosciences, Inc. misses on earnings expectations. Reported EPS ...

Why did Swedish nicotine pouches become a generation's go-to fix for blasting through long work days and longer nights out?

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...